US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

CLEVER LEAVES HOLDINGS INC

us-stock
To Invest in {{usstockname}}
us-stock
$3.15 0(0%) CLVR at 04 Dec 2025 04:28 PM Drug Manufacturers - Specialty & Generic
Lowest Today 2.2
Highest Today 3.04
Today’s Open 2.2
Prev. Close
52 Week High 8.40
52 Week Low 1.38
Day’s Range: Low 2.2 High 3.04
52-Week Range: Low 1.38 High 8.40
1 day return -
1 Week return -
1 month return -
3 month return -
6 month return -
1 year return -
3 year return -
5 year return -
10 year return -

Institutional Holdings

AdvisorShares Investments, LLC 1.98

AdvisorShares Pure Cannabis ETF 1.97

Renaissance Technologies Corp 1.97

Vanguard Group Inc 0.87

Vanguard Institutional Extnd Mkt Idx Tr 0.86

Geode Capital Management, LLC 0.61

BlackRock Inc 0.57

Amundi 0.48

Fidelity Extended Market Index 0.42

Penserra Capital Management, LLC 0.29

Amplify Seymour Cannabis ETF 0.29

Tower Research Capital LLC 0.12

Fidelity Total Market Index 0.07

BlackRock Extended Mkt Composite 0.07

BlackRock Extended Equity Market K 0.06

Fidelity Series Total Market Index 0.06

Northern Trust Extended Eq Market Idx 0.04

NT Ext Equity Mkt Idx Fd - L 0.04

NT Ext Equity Mkt Idx Fd - NL 0.03

Fidelity Nasdaq Composite Index 0.03

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.02

Spartan Total Market Index Pool E 0.02

SSgA U.S. Extended Market Index Class I 0.01

State St US Extended Mkt Indx NL Cl C 0.01

Extended Equity Market Fund M 0.01

State St US Ttl Mkt Indx SL Cl I 0.01

Northern Trust Wilshire 5000 0.00

NT US Market Cap Idx Fd - L 0.00

Morgan Stanley - Brokerage Accounts 0.00

Royal Bank of Canada 0.00

Advisor Group Holdings, Inc. 0.00

Wells Fargo & Co 0.00

UBS Group AG 0.00

Focused Wealth Strategies, INC. 0.00

FNY Investment Advisers, LLC 0.00

Market Status

Strong Buy: 0

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 3.93 M

PB Ratio 0.3283

PE Ratio 0.0

Enterprise Value -1.04 M

Total Assets 31.24 M

Volume 274129

Company Financials

Annual Revenue FY23:18571000 18.6M, FY22:17800000 17.8M, FY21:15374000 15.4M, FY20:12117000 12.1M, FY19:7834000 7.8M

Annual Profit FY23:4859000 4.9M, FY22:4330000 4.3M, FY21:6809000 6.8M, FY20:7413000 7.4M, FY19:3102000 3.1M

Annual Net worth FY23:-41630000 -41.6M, FY22:-66101000 -66.1M, FY21:-45631000 -45.6M, FY20:-41414000 -41.4M, FY19:-48130000 -48.1M

Quarterly Revenue Q1/2024:4638000 4.6M, Q4/2023:4638000 4.6M, Q3/2023:3820000 3.8M, Q2/2023:4981000 5.0M, Q1/2023:3978000 4.0M

Quarterly Profit Q1/2024:-577000 -0.6M, Q4/2023:-346000 -0.3M, Q3/2023:1942000 1.9M, Q2/2023:2726000 2.7M, Q1/2023:2234000 2.2M

Quarterly Net worth Q1/2024:-2223000 -2.2M, Q4/2023:-5085000 -5.1M, Q3/2023:-5138000 -5.1M, Q2/2023:-3595000 -3.6M, Q1/2023:-4081000 -4.1M

Fund house & investment objective

Company Information Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.

Organisation Drug Manufacturers - Specialty & Generic

Employees 296

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Andres Fajardo

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right